MRNA241206P59000
- 16.96
- 0.000.00%
Moderna Newsroom
Moderna Analyst Ratings
JPMorgan Adjusts Price Target on Moderna to $45 From $59, Maintains Underweight Rating
Jefferies Downgrades Moderna(MRNA.US) to Hold Rating, Cuts Target Price to $50
Baptista Upgrades Moderna to Buy, Price Target at $48
BioNTech Stock Has Been Hit Hard Since RFK Jr.'s Nomination. Why This Analyst Upgraded It. -- Barrons.com
Berenberg Bank Initiates Moderna(MRNA.US) With Hold Rating, Announces Target Price $42
Berenberg Bank Initiates Moderna(MRNA.US) With Hold Rating, Announces Target Price $42
Moderna Analyst Ratings
HSBC Upgrades Moderna to Buy From Hold, Adjusts Price Target to $58 From $82
Moderna Initiated at Underperform by Wolfe Research
Moderna Analyst Ratings
Wolfe Research Downgrades Moderna(MRNA.US) to Sell Rating, Cuts Target Price to $40
Deutsche Bank Adjusts Price Target on Moderna to $60 From $75, Keeps Hold Rating
Barclays lowered moderna's target price to $111.
A Quick Look at Today's Ratings for Moderna(MRNA.US), With a Forecast Between $60 to $112
Moderna Analyst Ratings
Moderna Price Target Cut to $111.00/Share From $125.00 by Barclays
Moderna Is Maintained at Overweight by Barclays
BofA Securities Adjusts Price Target on Moderna to $90 From $110, Maintains Neutral Rating
A Quick Look at Today's Ratings for Moderna(MRNA.US), With a Forecast Between $55 to $111